Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 80 results for dvt

  1. Ozanimod for treating moderately to severely active ulcerative colitis (TA828)

    Evidence-based recommendations on ozanimod (Zeposia) for treating moderately to severely active ulcerative colitis in adults when conventional or biological treatments cannot be tolerated or are not working well enough.

    Technology appraisal guidance
    Published
    5 October 2022
    View recommendations

    Sections for TA828

  2. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at moderately increased risk

    difference will it make to my chance of getting a blood clot such as deep vein thrombosis (DVT) or a blood clot in the...

  3. Familial breast cancer. Patient decision aid on taking tamoxifen to reduce the chance of developing breast cancer for premenopausal women at high risk

    difference will it make to my chance of getting a blood clot such as deep vein thrombosis (DVT) or a blood clot in the...

  4. Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolism (HTG376)

    Evidence-based recommendations on ultrasound enhanced catheter-directed thrombolysis for pulmonary embolism. This involves using ultrasound waves and a drug to break up the clot.

    HealthTech guidance
    Published
    26 June 2015
    View recommendations

    Sections for HTG376

  5. Dabigatran etexilate for preventing venous thromboembolism after hip or knee replacement surgery (TA157)

    Evidence-based recommendations on dabigatran etexilate (Pradaxa) for preventing venous thromboembolism after hip or knee replacement surgery in adults.

    Technology appraisal guidance
    Published
    24 September 2008
    View recommendations

    Sections for TA157

  6. Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism (TA287)

    Evidence-based recommendations on rivaroxaban (Xarelto) for treating pulmonary embolism and for preventing a further deep vein thrombosis or pulmonary embolism in adults.

    Technology appraisal guidance
    Published
    26 June 2013
    View recommendations

    Sections for TA287

  7. Dose strategies for people who are obese:- What is the clinical and cost effectiveness of weight-based dose-adjustment strategies of lowmolecular-weight heparin (LMWH) compared with fixed-dose strategies of LMWH for preventing VTE in people who are very obese (BMI over 35) who are admitted to hospital or having day procedures (including surgery and chemotherapy)?

    biological measures rather than clinical outcomes such as deep vein thrombosis (DVT) and bleeding events. It is important that there is...

    Research recommendation
    Published
    15 November 2018

  8. Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)

    Summary of the evidence on idarucizumab for reversing the anticoagulant effect of dabigtatran to inform local NHS planning and decision-making

    Evidence summary
    Published
    24 May 2016

  9. Cardiometabolic disease prevention and treatment guidelines

    thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism - Diabetes Guideline

    NICE guideline
    In development

  10. Direct oral anticoagulants for people with lower limb immobilisation:- What is the clinical and cost effectiveness of direct oral anticoagulants for preventing VTE in people with lower limb immobilisation?

    lower limb immobilisation for non-major orthopaedic surgery. Estimates of DVT risk in people with lower limb immobilisation, based on...

    Research recommendation
    Published
    15 November 2018

  11. Familial breast cancer. Patient decision aid on taking a medicine to reduce the chance of developing breast cancer for postmenopausal women at high risk

    difference will it make to my chance of getting a blood clot such as deep vein thrombosis (DVT) or a blood clot in the...

  12. Apixaban for preventing venous thromboembolism after hip or knee replacement surgery (TA245)

    Evidence-based recommendations on apixaban (Eliquis) for preventing venous thromboembolism after hip or knee replacement in adults.

    Technology appraisal guidance
    Published
    25 January 2012
    View recommendations

    Sections for TA245

  13. The geko device for reducing the risk of venous thromboembolism (HTG344)

    Evidence-based recommendations on the geko device for reducing the risk of venous thromboembolism.

    HealthTech guidance
    Published
    25 June 2014
    View recommendations

    Sections for HTG344

  14. Urinary incontinence and pelvic organ prolapse in women. Patient decision aid on surgery for vaginal vault prolapse

    lead to blood clots forming in the veins of the legs (called deep vein thrombosis, or DVT), or in the lungs (called...

  15. Familial breast cancer. Patient decision aid on taking a medicine to reduce the chance of developing breast cancer for postmenopausal women at moderately increased risk

    difference will it make to my chance of getting a blood clot such as deep vein thrombosis (DVT) or a blood clot in the...